BeyondSpring Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BeyondSpring Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $0.00.
- BeyondSpring Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $0.00.
- BeyondSpring Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- BeyondSpring Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $4.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2026-03-25 | |
| 2023-12-31 | $4.00K 10-K · filed 2025-03-27 | |
| 2021-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $83.00K 20-F · filed 2023-04-18 |
| 2021-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |